TINA MCCARTAN: Open Payments
NPI 1114390416 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 102 payments from 29 companies in 2025. Trend: 2023 $1,412 · 2024 $1,585 · 2025 $2,340
Food & beverage: $2,340
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $457 |
| Lilly USA, LLC | 11 | $241 |
| Radius Health, Inc. | 12 | $184 |
| Amgen Inc. | 9 | $149 |
| BETA BIONICS, INC. | 4 | $119 |
| Avvisto Therapeutics, LLC | 4 | $116 |
| Insulet Corporation | 5 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Sequel Med Tech, LLC | 3 | $81 |
Products named: Ozempic, Wegovy, Tymlos, MOUNJARO, JARDIANCE, iLet Bionic Pancreas, CYCLOSET, Omnipod.
Industry payments across TX — which companies pay providers there.
